Ledger.Open graph →
SEC Form D · Amendment · filed June 20, 2013

Apex Therapeutics, Inc

Offering
$2.5M
Sold
$2.5M
Exemption
—
Industry
Biotechnology
Location
INDIANAPOLIS, IN
Type
—

People & firms on this filing (9)

David B. Rose · Winston-Salem, NCDirectorMark R. Kelley · INDIANAPOLIS, INDirectorTimothy J. Tichenor · Indianapolis, INExecRobert Young · Glenwood Springs, CODirectorMartin F. Haslanger · INDIANAPOLIS, INExec · DirectorMark R. Kelley · Indianapolis, INDirectorHomer L. Pearce · INDIANAPOLIS, INDirectorTimothy J. Tichenor · Grand Rapids, MIExecDavid Broecher · Indianapolis, INDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗